Churchill Capital Corp XI (CCXI) is a Blank Checks company listed on NASDAQ. In the last 30 days Quantisnow tracked 50 wire items for CCXI, including 23 insider trades, 14 SEC filings and 6 offerings. The most recent was published Nov 7, 2026.
News · 26 weeks109+206%
2026-05-172026-11-08
Mix8390d
- SEC Filings40(48%)
- Insider23(28%)
- Offering13(16%)
- Other4(5%)
- 13D/G2(2%)
- Leadership1(1%)
Activity · 52 weeks13663 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERChief Operating Officer Hunter Jennifer was granted 3,220,699 stock options (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDEROfficer Lang Anastasia was granted 2,760,599 stock options (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERDirector Shelton Damion was granted 9,938,151 shares (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERChief Technology Officer Velagapudi Prasanna was granted 3,680,797 stock options (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERChief Financial Officer Beer Michael Thomas was granted 2,576,560 shares (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERChief Executive Officer Johnson Margaret L was granted 347,790 shares (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERChief Robot Officer Hurst Jonathan was granted 12,422,709 shares (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERChief Hardware Officer Marroquin Marco was granted 2,300,498 stock options (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERPresident Diez Daniel was granted 3,220,699 stock options (SEC Form 4)4 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Hunter Jennifer3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lang Anastasia3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Shelton Damion3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Diez Daniel3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Aberle Derek K3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Hurst Jonathan3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Marroquin Marco3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Johnson Margaret L3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Vale Mark3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Saintil Merline3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Beer Michael Thomas3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Gentin Pierre3 - Agility Robotics, Inc. (0002074973) (Issuer)
- INSIDERSEC Form 3 filed by new insider Velagapudi Prasanna3 - Agility Robotics, Inc. (0002074973) (Issuer)
- SECChurchill Capital Corp XI filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics8-K - Agility Robotics, Inc. (0002074973) (Filer)
- 13D/GAmendment: SEC Form SCHEDULE 13D/A filed by Churchill Capital Corp XISCHEDULE 13D/A - Churchill Capital Corp XI (0002074973) (Subject)
- INSIDEROfficer Klein Michael Stuart converted options into 14,525,000 shares (SEC Form 4)4 - Churchill Capital Corp XI (0002074973) (Issuer)
CCXI FAQ
8 questionsWhat does Churchill Capital Corp XI do?
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibitor for the treatment of anti-neutrophil cytoplasmic autoantibody-associated vasculitis; and completed Phase II clinical trial for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. The company is also developing CCX559, an...What is the latest news on CCXI?
In the last 30 days Quantisnow tracked 50 wire items for CCXI: 23 insider trades, 14 SEC filings, 6 offerings and 4 press releases and news items. The most recent was published on November 7, 2026.Where does CCXI stock trade?
Churchill Capital Corp XI (CCXI) is listed on NASDAQ.What sector and industry is CCXI in?
Churchill Capital Corp XI operates in the Finance sector, Blank Checks industry.When did Churchill Capital Corp XI go public?
Churchill Capital Corp XI (CCXI) completed its IPO in 2026.What are analysts saying about CCXI?
Across the last 8 analyst actions on Churchill Capital Corp XI, there were 6 upgrades and 0 downgrades. The most recent action was from Canaccord Genuity: Buy with a $81.00 price target on 2022-08-04. Recent price targets range from $31.00 to $110.00.What companies are similar to CCXI?
Notable peers in the same industry include HCAC (Hall Chadwick Acquisition Corp), TACO (Berto Acquisition Corp.), INV (Innventure Inc.), PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.). Compare CCXI side-by-side with any of them on Quantisnow.How can I track CCXI on Quantisnow?
Quantisnow aggregates Churchill Capital Corp XI's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CCXI to receive live email and push alerts on every new disclosure.